Medicare Enrolled
Dr. Kyoung Kim, MD
Hospitalist Physician · Anaheim, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Kim from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kim?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Kim
Dr. Kyoung Kim is a hospitalist physician in Anaheim, CA, with 16 years of NPI registration. Based on federal Medicare data, Dr. Kim performed 2,697 Medicare services across 1,032 unique beneficiaries.
Between the years covered by Open Payments, Dr. Kim received a total of $6,690 from 41 pharmaceutical and/or device companies across 244 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hospitalist physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Kim is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 16 years in practice
▲ Top 4% volume in CA
$6,690 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,697
Medicare services
Top 4% in CA for hospitalist physician
1,032
Unique beneficiaries
$68
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~169 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
632 | $110 | $160 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
491 | $67 | $140 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
263 | $8 | $10 |
| Home visit, established patient, moderate complexity A home visit for an established patient involving moderate medical decision making. The visit requires at least 40 minutes of time if time is used to determine the level of service. |
223 | $107 | $180 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
190 | $12 | $40 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
154 | $75 | $150 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
70 | $12 | $200 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
68 | $30 | $250 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
61 | $140 | $306 |
| 5% dextrose/normal saline (500 ml = 1 unit) | 59 | $1 | $100 |
| Home health plan of care certification Certification by a physician or allowed practitioner for Medicare-covered home health services under a home health plan of care. This includes contacting the home health agency and reviewing reports of patient status required by physicians. |
58 | $46 | $75 |
| Home visit, new patient, moderate complexity A home visit for a new patient involving moderate medical decision making, lasting at least 60 minutes. |
52 | $114 | $250 |
| Ceftriaxone antibiotic injection This code represents the administration of ceftriaxone sodium, an antibiotic medication. The charge is calculated for every 250 mg of the drug administered. |
52 | $0 | $10 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
50 | $33 | $40 |
| Flu vaccine, quadrivalent A flu shot containing four strains of the influenza virus to help prevent seasonal influenza infection. |
47 | $76 | $94 |
| Advance care planning consultation, first 30 min A session focused on discussing and documenting future healthcare preferences and goals. This service covers the initial 30 minutes of the planning discussion. |
47 | $74 | $120 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
42 | $136 | $220 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
39 | $1 | $8 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
29 | $12 | $50 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
27 | $100 | $130 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
15 | $109 | $260 |
| Hospital discharge day management, 30 minutes or less This service covers the final day of hospital care when the patient is being discharged. It includes coordination of care and instructions for the patient within a time frame of 30 minutes or less. |
15 | $68 | $150 |
| Home health plan of care re-certification A physician reviews the patient's status and contacts the home health agency to re-certify the plan of care without the patient being present. |
13 | $37 | $75 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
2.5% high complexity
10.4% medium
87.1% routine
Industry Payment Transparency
Open Payments through 2024 ↗$6,690
Total received (2018-2024)
Avg $956/year across 7 years
Top 3% in CA for hospitalist physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
41
Companies
244
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,690 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,287
2023
$558
2022
$1,510
2021
$1,772
2020
$951
2019
$135
2018
$477
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$258
Lilly USA, LLC
$193
Regeneron Healthcare Solutions, Inc.
$192
IRONWOOD PHARMACEUTICALS, INC
$122
GENZYME CORPORATION
$108
ABBVIE INC.
$89
Amgen Inc.
$86
Bayer Healthcare Pharmaceuticals Inc.
$41
Astellas Pharma US Inc
$39
Almatica Pharma LLC
$37
Otsuka America Pharmaceutical, Inc.
$26
Exact Sciences Corporation
$26
Sumitomo Pharma America, Inc.
$25
Merck Sharp & Dohme LLC
$23
Boehringer Ingelheim Pharmaceuticals, Inc.
$21
Top 3 companies account for 50.0% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$1,246
Lilly USA, LLC
$577
Regeneron Healthcare Solutions, Inc.
$532
AstraZeneca Pharmaceuticals LP
$520
ABBVIE INC.
$365
Boehringer Ingelheim Pharmaceuticals, Inc.
$291
Nestle HealthCare Nutrition Inc.
$236
Amarin Pharma Inc.
$233
Bayer HealthCare Pharmaceuticals Inc.
$226
GlaxoSmithKline, LLC.
$197
SEASPINE ORTHOPEDICS CORPORATION
$157
Novartis Pharmaceuticals Corporation
$157
PFIZER INC.
$151
AbbVie Inc.
$147
Ironwood Pharmaceuticals, Inc
$144
SANOFI-AVENTIS U.S. LLC
$125
Janssen Pharmaceuticals, Inc
$122
IRONWOOD PHARMACEUTICALS, INC
$122
Merck Sharp & Dohme Corporation
$122
E.R. Squibb & Sons, L.L.C.
$116
GENZYME CORPORATION
$108
Eisai Inc.
$100
Exact Sciences Corporation
$93
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$64
Astellas Pharma US Inc
$62
Almatica Pharma LLC
$60
SCILEX PHARMACEUTICALS INC.
$60
Bayer Healthcare Pharmaceuticals Inc.
$58
Merck Sharp & Dohme LLC
$41
Boston Scientific Corporation
$27
Otsuka America Pharmaceutical, Inc.
$26
Sumitomo Pharma America, Inc.
$25
Dova Pharmaceuticals
$23
IBSA Pharma Inc.
$22
Hikma Pharmaceuticals USA
$22
Eyevance Pharmaceuticals LLC
$22
Novo Nordisk Inc
$20
EISAI INC.
$19
RedHill Biopharma Inc.
$18
Genentech USA, Inc.
$18
ARBOR PHARMACEUTICALS, INC.
$15
Top 3 companies account for 35.2% of all-time payments
Associated products mentioned in payments ›
ANORO ELLIPTA · Aduhelm · Aimovig · BELSOMRA · BREZTRI · COLOGUARD · CREON · Cologuard Collection Kit · DUPIXENT · Dayvigo · Doptelet · ELIQUIS · ENTRESTO · EVENITY · Edarbi · FARXIGA · FORTEO · GEMTESA · GENERAL THERAPIES · GENERAL THERAPIES · GRALISE · JANUVIA · JARDIANCE · Kerendia · LINZESS · LOREEV XR · Licart · Linzess · MOUNJARO · MYRBETRIQ · Mariner · Mitigare · Movantik · Otezla · Ozempic · PNEUMOVAX 23 · PRALUENT · PREVNAR 13 · PREVNAR 20 · Prolia · RELISTOR · REXULTI · Repatha · SHINGRIX · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SYMBICORT · SYNJARDY · TRELEGY ELLIPTA · TRULICITY · Tobradex ST · VERQUVO · Vascepa · Veozah · XARELTO · XIFAXAN · Xofluza · ZENPEP · ZTLido
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 3% for hospitalist physician in CA.
Geographic Context
Hospitalist physicians within 10 mi
246
Per 100K population
7.8
County median income
$113,702
Nearest hospital
AHMC ANAHEIM REGIONAL MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Kim is a clinical cardiology specialist, with above-average Medicare volume (top 4% in CA), with low-engagement industry engagement in the top 3% of CA peers, with 16 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Kim experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Kim performed 632 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kim receive payments from pharmaceutical companies?
Yes. Dr. Kim received a total of $6,690 from 41 companies across 244 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kim's costs compare to other hospitalist physicians in Anaheim?
Dr. Kim's average Medicare payment per service is $68. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kim) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hospitalist Physicians in Anaheim
Browse hospitalist physicians in Anaheim ranked by procedure volume and transparency data.
Highest volume
Top Hospitalist Physicians in CA
Hospitalist physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hospitalist Physicians in CA
Which CA hospitalist physicians receive the most from drug and device companies.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
By company
Regeneron Healthcare Solutions, Inc. Payments to Doctors
See all physicians who received payments from Regeneron Healthcare Solutions, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology